Global Small Molecule Cancer Drugs Market 2020-2026: Expected to Double in Next 6 Year Period Reaching $130 Billion, Driven by New Drug Launches & Dynamic Clinical Pipeline
01 sept. 2020 04h04 HE
|
Research and Markets
Dublin, Sept. 01, 2020 (GLOBE NEWSWIRE) -- The "Global Small Molecule Cancer Drug Market, Drug Price, Dosage & Clinical Trials Insight 2026" report has been added to ResearchAndMarkets.com's...
Cognition Therapeutics Announces First Patient Dosed in SEQUEL Study of CT1812
27 août 2020 07h59 HE
|
Cognition Therapeutics, Inc.
Pittsburgh, Aug. 27, 2020 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., a clinical stage neuroscience company developing drugs that treat neurodegenerative disorders by regulating cellular...
RedHill Biopharma Announces Positive Recommendation from Independent Committee to Continue U.S. Phase 2 COVID-19 Study, and Approval of COVID-19 Phase 2/3 Study in Italy
27 août 2020 07h00 HE
|
RedHill Biopharma Ltd.
A pre-scheduled independent Safety Monitoring Committee (SMC) has recommended that the U.S. Phase 2 COVID-19 study with opaganib continue with no changes; the study is more than 50% enrolled and...
OncoBay Clinical and Vineti form strategic alliance to deliver integrated clinical trial solutions and supply chain automation for cell and gene therapies
25 août 2020 09h00 HE
|
Vineti
TAMPA, Fla. and SAN FRANCISCO, Aug. 25, 2020 (GLOBE NEWSWIRE) -- OncoBay Clinical, Inc., a full-service boutique contract research organization (CRO) specializing in complex oncology programs...
Novavax Initiates Phase 2 Portion of Phase 1/2 Clinical Trial of COVID-19 Vaccine
24 août 2020 09h00 HE
|
Novavax, Inc.
Primary objectives expand evaluation of immunogenicity and safetySecondary objectives include preliminary efficacy assessmentTrial to enroll up to 1,500 volunteers in United States and Australia, with...
COVID-19 Drug Candidate Brilacidin Achieves a Selectivity Index Among the Highest Reported, Exhibiting Potent Anti-SARS-CoV-2 Activity at Low Concentrations; Clinical Trial Forthcoming
24 août 2020 08h00 HE
|
Innovation Pharmaceuticals Inc.
Preliminary data shows Brilacidin’s Selectivity Index (SI), a ratio that compares a drug’s cytotoxicity and antiviral activity, to be greater than 300 in a human lung epithelial cell lineBrilacidin’s...
Entera Bio Ltd Announces Interim Data From Phase 2 Clinical Trial of EB613 in Osteoporosis and Second Quarter 2020 Financial Results
20 août 2020 06h30 HE
|
Entera Bio Ltd.
‒ 6-Month Interim Data Indicate EB 613 Has Meaningful and Positive Impact on Lumbar Spine Bone Mineral Density (BMD) in a Dose Dependent Manner –‒ Company Expects to Complete Patient Enrollment in...
Immatics weitet klinisches Studienprogramm für adoptive Zelltherapien auf Europa aus
18 août 2020 07h00 HE
|
Immatics N.V.
Tübingen, Deutschland und Houston, Texas, Aug. 18, 2020 (GLOBE NEWSWIRE) -- Der erste Patient in Deutschland wurde im Rahmen der Immatics‘ ACTengine® IMA202-101 Studie behandeltDie deutsche...
Immatics Announces European Clinical Expansion of its Adoptive Cell Therapy Programs
18 août 2020 07h00 HE
|
https://immatics.com/
Tuebingen, Germany and Houston, Texas, Aug. 18, 2020 (GLOBE NEWSWIRE) -- First patient has been treated in Germany in Immatics’ ACTengine® IMA202-101 trialGerman regulatory agency,...
Trevi Therapeutics Announces Second Quarter 2020 Financial Results and Business Update
13 août 2020 16h05 HE
|
Trevi Therapeutics
Announced Positive Outcome of Sample Size Re-Estimation Analysis for PRISM Trial Strong Enrollment in PRISM Trial After Lifting of COVID-19 Restrictions Announces $14 Million Term Loan - Cash...